(Reuters) – The U.S. Food and Drug Administration on Wednesday authorized Omicron-tailored COVID-19 booster shots from Moderna (NASDAQ:) Inc as well as Pfizer Inc (NYSE:) and its partner BioNTech SE (NASDAQ:) for children, a move that will boost the government’s fall vaccination campaign.
Be the first to comment